“In 2012, both the per capita use and cost of medicines declined. The cost curve for medicines if not for other elements of the U.S. healthcare system was bent. For some, this will be good news and a harbinger of more efficient use of our healthcare resources. For others, this decline may indicate under treatment and imbalance between prevention and care. Whichever the perspective, this years review of the utilization and cost of medicines and their role in the overall healthcare system brings forward important issues, especially as we sit on the eve of arguably the most transformative period in healthcare.”
Sabrina is the also the solo Editor/Publisher and Founder of LLRX.com® – Legal, technology and knowledge discovery resources on the “moving edge” for Librarians, Lawyers, Researchers, Academic and Public Interest Communities – launched in 1996.